歡迎訪問中科光析科學技術(shù)研究所官網(wǎng)!

免費咨詢熱線
400-635-0567|
組織工程醫(yī)療產(chǎn)品 殼聚糖檢測項目報價???解決方案???檢測周期???樣品要求? |
點 擊 解 答??![]() |
YY/T 0606的本部分規(guī)定了組織工程醫(yī)療產(chǎn)品分類標準的相關(guān)方面,以保證組織工程醫(yī)療產(chǎn)品對病人和使用者的安全和有效性。本部分不包括傳統(tǒng)意義上的器官和組織移植以及活細胞治療。 本部分適用于組織工程產(chǎn)品的分類要求,不包括其他標準中包括的特定內(nèi)容。
YY/T 0606的本部分規(guī)定了修復或再生關(guān)節(jié)軟骨的植入物體內(nèi)評價的通則。本部分中的植入物 可由天然或合成生物材料(具有生物相容性,可生物降解),或其復合物構(gòu)成,可含有細胞、藥物,或生長因子、合成多肽、質(zhì)?;騝DNA等生物活性因子。本部分描述了兔、犬、豬、山羊、綿羊等不同種屬的動物模型和相應的試驗程序,以及形態(tài)學、組織生物化學和生物力學分析等結(jié)果測定和評價的方法。
1.1 YY/T 0606的本部分規(guī)定了用于組織工程醫(yī)療產(chǎn)品(TEMPs)的細胞、組織和器官的加工處理、檢定、生產(chǎn)以及質(zhì)量保證的要求,包括: a) 細胞、組織及器官的加工處理(即:設(shè)施、試劑、接收程序、檢查以及貯存;組織培養(yǎng)成分,生物危險因子以及操作區(qū)域); b)供體(人源或非人源)及篩查; c)細胞、組織和器官的檢定及加工。1.2本部分不適用于現(xiàn)行藥品管理法中按照生物制品進行管理的產(chǎn)品。
YY/T 0606的本部分所述的原理和方法適用于絕大部分類型細胞的自動計數(shù),包括黏附生長細胞和懸浮生長細胞。
YY/T 0606的本部分規(guī)定了評價組織工程醫(yī)療產(chǎn)品基質(zhì)或支架所致哺乳動物體液免疫反應的試驗方法:ELISA法。本部分適用于組織工程醫(yī)療產(chǎn)品基質(zhì)或支架的生物學評價。除本部分所選方法外,可采納其他等效方法。并非所有的材料和應用均需要按照本部分進行檢測,因此應仔細考慮本部分中方法的適用性。在實施本部分推薦的試驗前,應考慮GB/T 16886.1或管理部門所推薦的試驗結(jié)果所提示的信息。
YY/T 0606的本部分規(guī)定了評價組織工程醫(yī)療產(chǎn)品基質(zhì)或支架所致哺乳動物細胞免疫反應的試驗方法:細胞遷移試驗。本部分適用于組織工程醫(yī)療產(chǎn)品基質(zhì)或支架的生物學評價。除本部分所選方法外,可采納其他等效方法。并非所有的材料和應用均需要按照本部分進行檢測,因此應仔細考慮本部分中方法的適用性。在實施本部分推薦的試驗前,應考慮GB/T 16886.1或管理部門所推薦的試驗結(jié)果所提示的信息。
本標準規(guī)定了醫(yī)用羧甲基殼聚糖原料的要求、試驗方法、包裝、運輸和貯存等。本標準適用于以殼聚糖或甲殼素為原料,經(jīng)脫乙?;?、羧化、純化而成的用于制造組織工程醫(yī)療器械產(chǎn)品的醫(yī)用羧甲基殼聚糖。
本標準給出了用于表征組織工程醫(yī)療器械產(chǎn)品中水凝膠的生物學特性、形成動力學、物理與化學特性及穩(wěn)定性,以及物質(zhì)傳遞等特性的方法指南。
本標準規(guī)定了組織工程醫(yī)療器械產(chǎn)品的基本術(shù)語和定義。
本標準規(guī)定了海藻酸鹽凝膠固定或微囊化評價的要求,包括海藻酸鹽凝膠固定或微囊化、微膠囊或微膠珠的性能及其考察、海藻酸鹽凝膠的生物相容性的考察。本標準適用于海藻酸鹽凝膠固定或微囊化的評價。
本標準規(guī)定了用于制備組織工程醫(yī)療器械產(chǎn)品的殼聚糖及其鹽的要求、試驗方法等。本標準適用于制備組織工程醫(yī)療器械產(chǎn)品的殼聚糖及其鹽。
1.1 This guide covers the evaluation of chitosan salts suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, tissue-engineered medical products (TEMPS).1.2 This guide addresses key parameters relevant for the functionality, characterization, and purity of chitosan salts.1.3 As with any material, some characteristics of chitosan may be altered by processing techniques (such as molding, extrusion, machining, assembly, sterilization, and so forth) required for the production of a specific part or device. Therefore, properties of fabricated forms of this polymer should be evaluated using test methods that are appropriate to ensure safety and efficacy.This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
4.1x00a0;This guide contains a listing of those characterization parameters that are directly related to the functionality of chitosan. This guide can be used as an aid in the selection and characterization of the appropriate chitosan or chitosan salt for a particular application. This standard is intended to give guidance in the methods and types of testing necessary to properly characterize, assess, and ensure consistency in the performance of a particular chitosan. It may have use in the regulation of devices containing chitosan by appropriate authorities. 4.2x00a0;The chitosan salts covered by this guide may be gelled, extruded, or otherwise formulated into biomedical devices for use as tissue-engineered medical products or drug delivery devices for implantation as determined to be appropriate, based on supporting biocompatibility and physical test data. Recommendations in this guide should not be interpreted as a guarantee of clinical success in any tissue-engineered medical product or drug delivery application. 4.3x00a0;To ensure that the material supplied satisfies requirements for use in TEMPs, several general areas of characterization should be considered. These include identity of chitosan, physical and chemical characterization and testing, impurities profile, and performance-related tests. 1.1x00a0;This guide covers the evaluation of chitosan salts suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, tissue-engineered medical products (TEMPS). 1.2x00a0;This guide addresses key parameters relevant for the functionality, characterization, and purity of chitosan salts. 1.3x00a0;As with any material, some characteristics of chitosan may be altered by processing techniques (such as molding, extrusion, machining, assembly, sterilization, and so forth) required for the production of a specific part or device. Therefore, properties of fabricated forms of this polymer should be evaluated using test methods that are appropriate to ensure safety and efficacy. 1.4x00a0;Warningx2014;Mercury has been designated by EPA and many state agencies as a hazardous material that can cause central nervous system, kidney, and liver damage. Mercury, or its vapor, may be hazardous to health and corrosive to materials. Caution should be taken when handling mercury and mercury-containing products. See the applicable product Material Safety Data Sheet (MSDS) for details and EPAx2019;s website (http://www.epa.gov/mercury/faq.htm) for additional information. Users should be aware that selling mercury or mercury-containing products, or both, in your state may be prohibited by state law. 1.5x00a0;The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard. 1.6x00a0;This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicabilit......
前沿科學
微信公眾號
中析研究所
抖音
中析研究所
微信公眾號
中析研究所
快手
中析研究所
微視頻
中析研究所
小紅書